We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

A potential breakthrough in the ongoing AIDS crisis could be deprioritized due to the decisions of noted vaccine skeptic Robert F. Kennedy, Jr.

Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human ...

The last large HIV vaccine study has been halted ahead of schedule after researchers determined "there is little or no chance of the trial demonstrating vaccine efficacy in preventing HIV acquisition, ...

While researchers found that the vaccines they tested were generally safe and well tolerated, 6.5% of study participants developed hives, a finding also seen in another mRNA-based HIV vaccine study.

A vaccine pharmacist prepares samples as part of an HIV vaccine trial on March 16, 2022 in Masaka, Uganda. The vaccine in that trial did not prove effective.